Advertisement
investing

Vanguard Health Care Hit Hard by Politics

This Kiplinger 25 fund is looking to get back on track with firms that push innovation.

Even great funds stumble occasionally. Case in point: Vanguard Health Care (VGHCX), which has delivered the highest return of any stock mutual fund over the past 30 years. After seven straight years of gains, Health Care lost 9% in 2016. And though its one-year return is now in the black, the fund trailed Standard & Poor’s 500-stock index by a decidedly unhealthy 17 percentage points over the past 12 months.

Problems for the fund, a member of the Kiplinger 25, stem mainly from troubles in its sector. Because health care makes up 18% of the U.S. economy, the sector often comes under fire during presidential election years, says the fund’s manager, Jean Hynes. In some election years, health care stocks take a hit before the vote; in others, it’s after. This time, “it was before and after,” she says.

Advertisement - Article continues below

Weighing most heavily on the sector were frequent denunciations of the high cost of pharmaceuticals and concerns that Congress might force drugmakers to roll back their prices. With 60% of Health Care’s assets invested in the catchall group that Hynes calls biopharmaceuticals, it’s no wonder her fund faltered. Changes to the Affordable Care Act loom, too, but Hynes says the structure of any new system would most likely be similar to what’s in place now and that any potential shifts would affect only 5% to 10% of the fund’s assets.

Hynes, who tilts toward large, undervalued firms with good long-term growth prospects, had her share of winners. UnitedHealth Group, a managed-care company and the fund’s top holding, returned 43% over the past year, buoyed by Optum, UnitedHealth’s fast-growing business that offers a broad array of health care serv­ices. And Incyte, a biotech firm that is developing drugs that target a body’s immune system to fight cancer, soared 72%.

Incyte is a good example of the kind of company Hynes favors. She is focusing on investing in established firms that have swiftly adapted or new ones that are pioneers—companies that are “ahead of the curve in terms of innovation,” she says, and that have rich pipelines of new drugs. One such company is Biogen, which recently won regulatory approval for the first drug to treat spinal muscular atrophy, a rare and often fatal genetic muscle disease.

Advertisement
Advertisement

Most Popular

How To Buy a Roth IRA When You Make Too Much To Qualify For One
Roth IRAs

How To Buy a Roth IRA When You Make Too Much To Qualify For One

With their tax-free growth and tax-free withdrawals, Roth IRAs are a great deal — if you qualify. If you don’t, well, there’s still a way to get into …
September 23, 2020
Social Security Recipients, Veterans Must Act Now to Get Extra $500 Stimulus Check
Coronavirus and Your Money

Social Security Recipients, Veterans Must Act Now to Get Extra $500 Stimulus Check

The deadline for seniors and veterans to request an additional $500 stimulus check for a dependent child is approaching fast. See how you can claim yo…
September 25, 2020
High-Tech Aids for Aging in Place
Caregiving

High-Tech Aids for Aging in Place

Apple Watch and other technology provides fast feedback, comfort for older users, and a powerful assist for caregivers.
September 23, 2020

Recommended

Trump Promises $200 Prescription Drug Card for Seniors
Medicare

Trump Promises $200 Prescription Drug Card for Seniors

Medicare beneficiaries will soon receive a debit card in the mail that they can use to pay for prescription drugs.
September 25, 2020
10 of the Best Target-Date Fund Families
mutual funds

10 of the Best Target-Date Fund Families

The best target-date funds are a 'set it and forget it' approach to your retirement, but which fund family should you trust your money?
September 17, 2020
3 Tips to Help You Navigate Open Enrollment in Your ‘New Normal’
health insurance

3 Tips to Help You Navigate Open Enrollment in Your ‘New Normal’

With all the changes going on in workplaces across the country since COVID-19, your insurance and benefits needs might have changed, too.
September 15, 2020
Best Bond Funds for Every Need
Investing for Income

Best Bond Funds for Every Need

In a changing market, it’s important to remember why we hold bonds in the first place.
September 15, 2020